"Inflammatory Bowel Disease May Mimic Gynecological Disorders In Clinical Presentation." ScienceDaily. ScienceDaily, 22 February 2008. <www.sciencedaily.com / releases / 2008 / 02 / 080222101604.htm>.

First participants have been successfully dosed in a Phase I Clinical Trial of MAP 315, Microba’s lead Therapeutic Program in Inflammatory Bowel Disease. MAP 315, is a novel live biotherapeutic ...

Iterative Scopes is a pioneer in the application of artificial intelligence-based precision medicine for gastroenterology with the aim of helping to optimize clinical trials investigating ...

First participants have been successfully dosed in a Phase I Clinical Trial of MAP 315, Microba’s lead Therapeutic Program in Inflammatory Bowel Disease. MAP 315, is a novel live biotherapeutic ...